Birth of a Field
It wasn't exactly the birth of a new field in precise terms, but at the time there weren't many people trying to attach mathematical formulas to cellular processes. There were basically no books, no academic courses, no review articles, and typical biology journals would look suspiciously at any type of work that involved complex math calculations. Since my arrival in the US, the number of people interested in quantitative biology has grown tremendously. Now there are entire departments, institutes, and many specialized journals that cover the fields of systems and computational biology.
At Princeton, I studied cellular networks, looking at the way in which certain intracellular processes affect each other to get cells going. The system we chose to study was a well known DNA sequence governing lactose metabolism in the E. coli bacterium known as lac operon. This is one of the systems that in the 1950s led to the whole field of gene regulation and it is extremely well characterized. There was all this molecular information about it, including sequence and the detailed three-dimensional structures of all its components, and yet it was not possible to predict what the effect of precise mutations would be in the behavior of E. coli. We developed mathematical models that can tell you how molecules bind to DNA, how cells change their state in response to lactose, and how populations of cells grow together. More importantly, these models can reveal how everything fits together.
After three years at Princeton, I moved with the Leibler lab to The Rockefeller University in 2001. One of the reasons for my making the move was geographic. It was attractive to me, coming from Barcelona, to live in New York City. For the next two years at Rockefeller, I continued the research I had begun in Princeton.
Memorial Sloan-Kettering
When I considered my next steps, I knew I wanted to stay in New York. The newly created Computational Biology Program at Memorial Sloan-Kettering, together with an impressive group of scientists, provided the perfect environment.
My own lab started here in 2004 and I wanted to study more human health-related systems. The system we had studied, the lac operon in E. coli, was fairly complex, but still it is one of the simplest biological systems. If you wanted to study something more complex, like human cells, you couldn't use conventional computational methods, which meant we had to develop new tools.
We want to understand how a system works quantitatively so that we can be able to control it. Take a car as an example. Stopping a car on a slippery road can be very challenging. If you brake strongly and the wheels get locked, you can lose control of the car and it may spin. Anti-lock braking systems, known as ABS, have been designed to substitute regular braking under such slippery conditions. In the most sophisticated setups, each wheel is monitored independently, and a control mechanism computes the pressure that should be applied to slow down each wheel independently to stop the car. This type of control requires a concrete model connecting the speed of the wheels with the motion of the car.
I wanted to create computational models of cellular processes to be able to predict the behavior of the cell and to learn how to control it. For instance, it is now understood that many diseases cannot be cured with a single drug, the so-called "silver bullet" approach. They are more complex and most likely will need a combination of drugs and therapies tailored to each particular individual. If you have a patient, you can't try many pharmaceutical combinations to see which ones work, in the same way as you can't try braking in different ways when you are driving on a slippery road. Using computational and mathematical tools, we hope someday in the not-too-distant future to build and use models to test which drug combinations will work on various cancers. We are quite far from these models, but we have the resources dedicated to get there.